Empowering interstitial lung disease patients with digital health tech
Dr. Bipin Patel, CEO and Founder of electronRx, a deep-tech startup developing novel chronic disease and hospital patient management solutions,...
interstitial
Research aims to improve interstitial lung disease prognosis with new imaging agent
Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker...
Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease
LONDON, Sept. 10, 2024 /PRNewswire/ -- Serac Healthcare Limited ("Serac Healthcare" or "the Company"), a clinical radiopharmaceutical company developing innovative...
